ArticleFrontiers in medicine2026
Combined use of ultrasonography and point shear wave elastography for the assessment of renal diseases.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the progression of renal diseases across different stages of chronic kidney disease (CKD) using a combination of conventional ultrasonography and point shear wave elastography (pSWE). Methods: This study enrolled patients who were regularly followed up at our hospital outpatient clinic between January 2025 and September 2025 and who underwent renal ultrasonography, pSWE, and laboratory testing. The sample size was calculated based on the single population proportion formula ( Results: Renal elasticity values increased progressively from CKD stage 1 to stage 5 hemodialysis patients ( Conclusion: pSWE can non-invasively and quantitatively detect changes in renal tissue stiffness. It provides a valuable imaging biomarker for differentiating between various pathological types and phenotypes of renal diseases, as well as assessing disease severity and fibrosis degree. This study supports the integrated use of pSWE with grayscale ultrasound and Doppler for comprehensive renal evaluation, assisting clinical decision-making and reducing unnecessary renal biopsies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.